Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • Advancing NeuroMRI with High-Relaxivity Contrast Agents
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in
  • Log out

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in
  • Log out

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • Advancing NeuroMRI with High-Relaxivity Contrast Agents
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates


Improved Turnaround Times | Median time to first decision: 12 days

Atypical Meningioma, WHO Grade II, Invasive

  • Background—General:
    • Meningiomas are the most common extra-axial neoplasms and account for 15% of all intracranial tumors.
    • Three grades exist based on the WHO criteria. Most are WHO Grade I; approximately 6% are WHO Grade II; and rare are WHO Grade III neoplasms (malignant with metastatic potential).
    • Many variants of meningioma have been described in the literature.
    • Atypical meningiomas fall under WHO Grade II tumors, accounting for 5–15% of all meningiomas.
    • The incidence of reporting of these tumors has increased since revision to the WHO classification in 2007.
  • Background—Pediatric/Infantile Meningioma:
    • Pediatric meningiomas are rare and account for fewer than 5% of all pediatric intracranial neoplasms.
    • Infantile meningiomas (< 12 months old) are even rarer, with fewer than 30 reported cases.
    • Pediatric patients usually present with increased intracranial pressure and seizures.
    • Intraventricular and skull base locations are more common in children relative to adults.
    • Risk factors for pediatric meningiomas include neurofibromatosis II and prior radiation therapy.
    • There is a higher incidence of atypical or aggressive subtypes in pediatric patients.
  • Key Diagnostic Imaging Features:
    • Brain CT shows an intra-axial or extra-axial mass with bone destruction. The tumor is usually hyperdense with peritumoral edema but minimal or no calcification.
    • Brain MRI shows indistinct tumor margins with infiltrating tumor interdigitating with normal brain parenchyma on T1 weighted imaging. T2WI and FLAIR images show peritumoral edema. Postcontrast imaging typically shows an enhancing tumor that involves both the skull and scalp. MRV may show dural sinus invasion.
    • Conventional angiography shows an intense vascular stain that appears early and persists late. The venous phase may show dural sinus invasion.
    • Typical imaging findings of meningioma do not exclude atypical variants. Histology is needed for definitive diagnosis.
  • Histology:
    • 4–19 mitotic figures/10 HPF OR
    • Brain Invasion OR
    • Three of the following histologic features:
      • Increased cellularity
      • Small cells that have high nuclear to cytoplasmic ratio
      • Large nucleoli
      • Loss of lobular architecture
      • Geographic areas of necrosis
  • Differential Diagnosis:
    • Typical meningioma: Usually noninvasive, but histology is needed for definitive diagnosis.
    • Dural metastasis: Extracranial neoplasm is usually known (eg, neuroblastoma)
    • Lymphoma: Often lytic bone lesion with epidural and extracranial components
    • Ewing sarcoma: Often osseous laminated periosteal reaction
  • Treatment:
    • Gross total or subtotal resection is usually performed, followed by adjunctive radiation therapy. Stereotactic radiosurgery also plays a role.
    • Currently, there are no effective chemotherapeutic agents available.
    • Atypical meningiomas are uncommon and have poorer prognosis when compared to benign meningiomas. Atypical meningiomas have a recurrence rate of 28%. The 5-year survival rate is estimated to be 86%, while the 5-year recurrence-free survival is estimated to be 48%.
April 2016

An 11-month-old boy with right-sided neurologic deficits

View Case
  • Read more about 2016apr
  • Comments
Advertisement
Subscribe to RSS - Atypical Meningioma, WHO Grade II, Invasive

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire